Glucagon-like peptide-1 7-36 amide

Drug Profile

Glucagon-like peptide-1 7-36 amide

Alternative Names: GLP-1 (7-36) amide

Latest Information Update: 29 Jun 2004

Price : $50

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Novo Nordisk
  • Class Glucagon-like peptides
  • Mechanism of Action Gastric inhibitory polypeptide stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Obesity; Type 2 diabetes mellitus

Most Recent Events

  • 29 Jun 2004 Discontinued - Clinical-Phase-Unknown for Type-2 diabetes mellitus in United Kingdom (SC)
  • 29 Jun 2004 Discontinued - Phase-II for Type-2 diabetes mellitus in Denmark (Infusion)
  • 29 Jun 2004 Discontinued - Clinical-Phase-Unknown for Type-2 diabetes mellitus in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top